Stocks Making the Biggest Moves Midday: Bristol-Myers Squibb, Twitter, Gilead Sciences and More

— Amgen shares fell 3.7% after the approval of Bristol-Myer Squibb's psoriasis drug, which will compete with Amgen's Otezla.

Separately, the biotech company reported over the weekend that its Lumakras pill reduced the risk of lung cancer progression by 34% compared with chemotherapy in a clinical trial,

Wij hebben dit nieuws samengevat zodat u het snel kunt lezen. Bent u geïnteresseerd in het nieuws, dan kunt u hier de volledige tekst lezen. Lees verder:

nbcsandiego /  🏆 524. in NL

Nederland Laatste Nieuws, Nederland Headlines

Similar News:Je kunt ook nieuwsberichten lezen die vergelijkbaar zijn met deze die we uit andere nieuwsbronnen hebben verzameld.

Stocks Making the Biggest Moves Premarket: Carvana, Bristol-Myers Squibb, Alphatec and MoreThese are the stocks posting the largest moves in premarket trading.
Bron: nbcsandiego - 🏆 524. / 51 Lees verder »

Twitter whistleblower testimony, consumer price index, Oracle earnings top week aheadFOX Business takes a look at the upcoming events that are likely to move financial markets in the coming days, including some big matters for Twitter. “Every statue and street building has been renamed, every date has been altered. And the process is continuing day by day and minute by minute. History has stopped. Nothing exists except an endless present in which the Party is always right.” - George Orwell, 1984
Bron: FoxBusiness - 🏆 458. / 53 Lees verder »